You are here

  • Home
  • Online First
  • A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group

Article info

Article menu

other Versions

Download PDFPDF

Corners of the world
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group
Free

Authors

  • Michele Bartoletti Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy PubMed articlesGoogle scholar articles
  • Alice Bergamini Department of Obstetrics and Gynecology, IRCCS, San Raffaele Hospital, Ospedale San Raffaele, Milan, Italy PubMed articlesGoogle scholar articles
  • Gaia Giannone Department of Oncology, University of Turin, Torino, Piemonte, ItalyOvarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Camilla Nero Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articlesGoogle scholar articles
  • Lucia Musacchio Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articlesGoogle scholar articles
  • Alberto Farolfi Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Emilia-Romagna, Italy PubMed articlesGoogle scholar articles
  • Anna Passarelli Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy PubMed articlesGoogle scholar articles
  • Elisabetta Kuhn Department of Biomedical, Surgical, and Dental Sciences, Università degli Studi di Milano, Milan, ItalyDivision of Pathology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy PubMed articlesGoogle scholar articles
  • Daniele Castaldo Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) Group Secretariat, Napoli, Italy PubMed articlesGoogle scholar articles
  • Valentina Lombardo Department of Medical Oncology, Azienda Ospedaliera per l'Emergenza Cannizzaro, Catania, Italy PubMed articlesGoogle scholar articles
  • Teresa Di Palma Oncologia Medica, Ospedale S Maria Goretti, Latina, Italy PubMed articlesGoogle scholar articles
  • Domenica Lorusso Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDepartment of Life Science and Public Health, Policlinico Universitario Agostino Gemelli Dipartimento Scienze della Salute della Donna e del Bambino, Rome, Lazio, Italy PubMed articlesGoogle scholar articles
  • Fabio Puglisi Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano, ItalyDepartment of Medicine, University of Udine, Udine, Italy PubMed articlesGoogle scholar articles
  • Ugo De Giorgi Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Emilia-Romagna, Italy PubMed articlesGoogle scholar articles
  • Giorgio Valabrega Department of Oncology, University of Turin, Torino, Piemonte, Italy PubMed articlesGoogle scholar articles
  • Clorinda Schettino Clinical Trials Unit, National Cancer Institute IRCCS Pascale Foundation, Napoli, Italy PubMed articlesGoogle scholar articles
  • Giovanni Scambia Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDepartment of Life Science and Public Health, Policlinico Universitario Agostino Gemelli Dipartimento Scienze della Salute della Donna e del Bambino, Rome, Lazio, Italy PubMed articlesGoogle scholar articles
  • Ettore Capoluongo Department of Clinical Pathology, Azienda Ospedaliera per l'Emergenza Cannizzaro, Catania, Italy PubMed articlesGoogle scholar articles
  • Sandro Pignata Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Sandro Pignata, Gynaecological Oncology, National Cancer Institute Napels, 07103 Naples, Italy; s.pignata{at}istitutotumori.na.it

Citation

Bartoletti M, Bergamini A, Giannone G, et al
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group
International Journal of Gynecologic Cancer Published Online First: 21 March 2022. doi: 10.1136/ijgc-2022-003425

Publication history

  • Accepted February 17, 2022
  • First published March 21, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.